MannKind MNKD shares moved up 11.30% to $11.13. The volume of MannKind shares traded was 784% higher than normal. MannKind jumped following the conditional FDA approval for Afrezzaa.
Dicerna Pharmaceuticals DRNA shares rose 14.92% to $21.65. The volume of Dicerna Pharmaceuticals shares traded was 545% higher than normal. Dicerna Pharma jumped on promising clinical data for DCR-PH1
Flamel Technologies SA FLML surged 5.75% to $14.87. The volume of Flamel Technologies shares traded 350% higher than normal. Flamel Tech announced the FDA approval of VAZCULEP.
GW Pharmaceuticals plc GWPH shares climbed 7.51% to $103.36. The volume of GW Pharmaceuticals shares traded was 280% higher than normal. Piper Jaffray raised the price target on GW Pharma from $97 to $147.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in